Top

BMC Neurology

Published in:

Open Access 01-12-2016 | Research article

Apolipoprotein E polymorphism and the risk of intracranial aneurysms in a Chinese population

Authors: Hao Liu, Ping Mao, Changhou Xie, Wanfu Xie, Maode Wang, Haitao Jiang

Published in: BMC Neurology | Issue 1/2016

Abstract

Background

The relationship between the apolipoprotein E (APOE) polymorphism and intracranial aneurysms has previously only been studied in Russia and Japan but not in Chinese populations. The purpose of this study was to investigate the association between APOE polymorphism and the risk of intracranial aneurysms in a Chinese population.

Methods

The study population consisted of 150 intracranial aneurysms patients and 150 matched control subjects. The APOE gene polymorphism was analyzed using polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP).

Results

Patients with intracranial aneurysms had a significantly higher frequency of APOE E2/E2 genotype [odds ratio (OR) =9.51, 95 % confidence interval (CI) = 1.19, 76.04; P = 0.03] and APOE E2/E3 genotype (OR = 1.87, 95 % CI = 1.03, 3.40; P = 0.04) than healthy controls. The APOE E4/E4 genotype frequencies (OR = 0.09, 95 % CI = 0.01, 0.74; P = 0.03) in the intracranial aneurysms group were significantly lower than those in the controls group. When stratified by the site, shape, size and the Fisher Grade of intracranial aneurysms, no statistically significant result was observed.

Conclusion

Our study suggested that APOE polymorphism might be associated with intracranial aneurysms in Chinese population. Additional studies are needed to confirm this finding.

Rinkel GJ, Djibuti M, Algra A, van Gijn J. Prevalence and risk of rupture of intracranial aneurysms: a systematic review. Stroke. 1998;29(1):251–6.CrossRefPubMed

Inagawa T. Trends in incidence and case fatality rates of aneurysmal subarachnoid hemorrhage in Izumo City, Japan, between 1980-1989 and 1990-1998. Stroke. 2001;32(7):1499–507.CrossRefPubMed

Broderick JP, Viscoli CM, Brott T, Kernan WN, Brass LM, Feldmann E, et al. Major risk factors for aneurysmal subarachnoid hemorrhage in the young are modifiable. Stroke. 2003;34(6):1375–81. doi:10.1161/01.STR.0000074572.91827.F4.CrossRefPubMed

Ruigrok YM, Rinkel GJ, Wijmenga C. Genetics of intracranial aneurysms. Lancet Neurol. 2005;4(3):179–89. doi:10.1016/S1474-4422(05)01015-X.CrossRefPubMed

Nahed BV, Bydon M, Ozturk AK, Bilguvar K, Bayrakli F, Gunel M. Genetics of intracranial aneurysms. Neurosurgery. 2007;60(2):213–25. doi:10.1227/01.NEU.0000249270.18698.BB. discussion 25-6.CrossRefPubMed

Foroud T, Lai D, Koller D, Van’t Hof F, Kurki MI, Anderson CS, et al. Genome-wide association study of intracranial aneurysm identifies a new association on chromosome 7. Stroke. 2014;45(11):3194–9. doi:10.1161/STROKEAHA.114.006096.CrossRefPubMedPubMedCentral

Bakir-Gungor B, Sezerman OU. The identification of pathway markers in intracranial aneurysm using genome-wide association data from two different populations. PLoS One. 2013;8(3):e57022. doi:10.1371/journal.pone.0057022.CrossRefPubMedPubMedCentral

Low SK, Takahashi A, Cha PC, Zembutsu H, Kamatani N, Kubo M, et al. Genome-wide association study for intracranial aneurysm in the Japanese population identifies three candidate susceptible loci and a functional genetic variant at EDNRA. Hum Mol Genet. 2012;21(9):2102–10. doi:10.1093/hmg/dds020.CrossRefPubMed

Yasuno K, Bilguvar K, Bijlenga P, Low SK, Krischek B, Auburger G, et al. Genome-wide association study of intracranial aneurysm identifies three new risk loci. Nat Genet. 2010;42(5):420–5. doi:10.1038/ng.563.CrossRefPubMedPubMedCentral

10.

Smalinskiene A, Petkeviciene J, Luksiene D, Jureniene K, Klumbiene J, Lesauskaite V. Association between APOE, SCARB1, PPARalpha polymorphisms and serum lipids in a population of Lithuanian adults. Lipids Health Dis. 2013;12:120. doi:10.1186/1476-511X-12-120.CrossRefPubMedPubMedCentral

11.

Boulenouar H, Mediene Benchekor S, Meroufel DN, Lardjam Hetraf SA, Ouhaibi Djellouli H, Hermant X, et al. Impact of APOE gene polymorphisms on the lipid profile in an Algerian population. Lipids Health Dis. 2013;12:155. doi:10.1186/1476-511X-12-155.CrossRefPubMedPubMedCentral

12.

Eichner JE, Dunn ST, Perveen G, Thompson DM, Stewart KE, Stroehla BC. Apolipoprotein E polymorphism and cardiovascular disease: a HuGE review. Am J Epidemiol. 2002;155(6):487–95.CrossRefPubMed

13.

Lebedeva ER, Sakovich VP, Khusainova RI, Kutuev IA, Valiev RR, Khusnutdinova NN, et al. The role of angiotensin-converting enzyme and apolipoprotein E in the development of intracranial aneurysms. Zh Nevrol Psikhiatr Im S S Korsakova. 2007;107(10):52–7.PubMed

14.

Mineharu Y, Inoue K, Inoue S, Yamada S, Nozaki K, Takenaka K, et al. Association analysis of common variants of ELN, NOS2A, APOE and ACE2 to intracranial aneurysm. Stroke. 2006;37(5):1189–94. doi:10.1161/01.STR.0000217408.91389.4d.CrossRefPubMed

15.

Glasker S, Schatlo B, Klingler JH, Braun V, Spangenberg P, Kim IS, et al. Associations of collagen type I alpha2 polymorphisms with the presence of intracranial aneurysms in patients from Germany. J Stroke Cerebrovasc Dis. 2014;23(2):356–60. doi:10.1016/j.jstrokecerebrovasdis.2013.04.038.CrossRefPubMed

16.

Li LJ, Pan XM, Sima X, Li ZH, Zhang LS, Sun H, et al. Interactions of interleukin-12A and interleukin-12B polymorphisms on the risk of intracranial aneurysm. Mol Biol Rep. 2012;39(12):11217–23. doi:10.1007/s11033-012-2031-z.CrossRefPubMed

17.

Zheng S, Su A, Sun H, You C. The association between interleukin-6 gene polymorphisms and intracranial aneurysms: a meta-analysis. Hum Immunol. 2013;74(12):1679–83. doi:10.1016/j.humimm.2013.08.274.CrossRefPubMed

18.

Li L, Sima X, Bai P, Zhang L, Sun H, Liang W, et al. Interactions of miR-34b/c and TP53 polymorphisms on the risk of intracranial aneurysm. Clin Dev Immunol. 2012;2012:567586. doi:10.1155/2012/567586.PubMedPubMedCentral

19.

Yang S, Wang T, You C, Liu W, Zhao K, Sun H, et al. Association of polymorphisms in the elastin gene with sporadic ruptured intracranial aneurysms and unruptured intracranial aneurysms in Chinese patients. Int J Neurosci. 2013;123(7):454–8. doi:10.3109/00207454.2013.763803.CrossRefPubMed

20.

McColgan P, Thant KZ, Sharma P. The genetics of sporadic ruptured and unruptured intracranial aneurysms: a genetic meta-analysis of 8 genes and 13 polymorphisms in approximately 20,000 individuals. J Neurosurg. 2010;112(4):714–21. doi:10.3171/2009.8.JNS092.CrossRefPubMed

21.

Sima X, Xu J, Li J, You C. Association between NFKB1 -94 insertion/deletion ATTG polymorphism and risk of intracranial aneurysm. Genet Test Mol Biomarkers. 2013;17(8):620–4. doi:10.1089/gtmb.2013.0110.CrossRefPubMedPubMedCentral

22.

Weinsheimer S, Goddard KA, Parrado AR, Lu Q, Sinha M, Lebedeva ER, et al. Association of kallikrein gene polymorphisms with intracranial aneurysms. Stroke. 2007;38(10):2670–6. doi:10.1161/STROKEAHA.107.486225.CrossRefPubMed

23.

Liu Y, Li P, Hu X, Hu Y, Sun HG, Ma WC, et al. Angiotensin-converting enzyme insertion/deletion gene polymorphism and risk of intracranial aneurysm in a Chinese population. J Int Med Res. 2013;41(4):1079–87. doi:10.1177/0300060513487625.CrossRefPubMed

24.

Chen Z, Ma J, Cen Y, Liu Y, You C. The angiotensin converting enzyme insertion/deletion polymorphism and intracranial aneurysm: a meta-analysis of case-control studies. Neurol India. 2013;61(3):293–9. doi:10.4103/0028-3886.115071.CrossRefPubMed

25.

Pannu H, Kim DH, Guo D, King TM, Van Ginhoven G, Chin T, et al. The role of MMP-2 and MMP-9 polymorphisms in sporadic intracranial aneurysms. J Neurosurg. 2006;105(3):418–23. doi:10.3171/jns.2006.105.3.418.CrossRefPubMed

26.

Peters DG, Kassam A, St Jean PL, Yonas H, Ferrell RE. Functional polymorphism in the matrix metalloproteinase-9 promoter as a potential risk factor for intracranial aneurysm. Stroke. 1999;30(12):2612–6.CrossRefPubMed

27.

Yin YW, Li JC, Wang JZ, Li BH, Pi Y, Yang QW, et al. Association between apolipoprotein E gene polymorphism and the risk of vascular dementia: a meta-analysis. Neurosci Lett. 2012;514(1):6–11. doi:10.1016/j.neulet.2012.02.031.CrossRefPubMed

28.

Rubino E, Vacca A, Govone F, De Martino P, Pinessi L, Rainero I. Apolipoprotein E polymorphisms in frontotemporal lobar degeneration: a meta-analysis. Alzheimers Demen. 2013;9(6):706–13. doi:10.1016/j.jalz.2012.10.013.CrossRef

29.

Yu B, Chen W, Wang R, Qi Q, Li K, Zhang W, et al. Association of apolipoprotein E polymorphism with maximal oxygen uptake after exercise training: a study of Chinese young adult. Lipids Health Dis. 2014;13(1):40. doi:10.1186/1476-511X-13-40.CrossRefPubMedPubMedCentral

30.

Zhou TB, Qin YH, Xu HL. Association of apoE gene expression and its gene polymorphism with nephrotic syndrome susceptibility: a meta-analysis of experimental and human studies. Mol Biol Rep. 2012;39(10):9347–54. doi:10.1007/s11033-012-1751-4.CrossRefPubMed

31.

Stoumpos S, Hamodrakas SJ, Anthopoulos PG, Bagos PG. The association between apolipoprotein E gene polymorphisms and essential hypertension: a meta-analysis of 45 studies including 13,940 cases and 16,364 controls. J Hum Hypertens. 2013;27(4):245–55. doi:10.1038/jhh.2012.37.CrossRefPubMed

32.

Zhu S, Wang Z, Wu X, Shu Y, Lu D. Apolipoprotein E polymorphism is associated with lower extremity deep venous thrombosis: color-flow Doppler ultrasound evaluation. Lipids Health Dis. 2014;13:21. doi:10.1186/1476-511X-13-21.CrossRefPubMedPubMedCentral

33.

Han Y, Liu T, Lu L. Apolipoprotein E gene polymorphism in psoriasis: a meta-analysis. Arch Med Res. 2013;44(1):46–53. doi:10.1016/j.arcmed.2012.10.009.CrossRefPubMed

34.

Meng HX, Qi MG, Yi YY, Liu YP. Association between apolipoprotein E gene polymorphism and the risk of recurrent pregnancy loss: a meta-analysis. J Assist Reprod Genet. 2013;30(12):1547–52. doi:10.1007/s10815-013-0118-7.CrossRefPubMedPubMedCentral

35.

Yin YW, Zhang YD, Wang JZ, Li BH, Yang QW, Fang CQ, et al. Association between apolipoprotein E gene polymorphism and the risk of multiple sclerosis: a meta-analysis of 6977 subjects. Gene. 2012;511(1):12–7. doi:10.1016/j.gene.2012.09.010.CrossRefPubMed

36.

Wang QY, Wang WJ, Wu L, Liu L, Han LZ. Meta-analysis of APOE epsilon2/epsilon3/epsilon4 polymorphism and cerebral infarction. J Neural Transm. 2013;120(10):1479–89. doi:10.1007/s00702-013-1019-8.CrossRefPubMed

37.

Gong JS, Kobayashi M, Hayashi H, Zou K, Sawamura N, Fujita SC, et al. Apolipoprotein E (ApoE) isoform-dependent lipid release from astrocytes prepared from human ApoE3 and ApoE4 knock-in mice. J Biol Chem. 2002;277(33):29919–26. doi:10.1074/jbc.M203934200.CrossRefPubMed

38.

Fagan AM, Holtzman DM, Munson G, Mathur T, Schneider D, Chang LK, et al. Unique lipoproteins secreted by primary astrocytes from wild type, apoE (-/-), and human apoE transgenic mice. J Biol Chem. 1999;274(42):30001–7.CrossRefPubMed

39.

Buttini M, Orth M, Bellosta S, Akeefe H, Pitas RE, Wyss-Coray T, et al. Expression of human apolipoprotein E3 or E4 in the brains of Apoe-/- mice: isoform-specific effects on neurodegeneration. J Neurosci. 1999;19(12):4867–80.PubMed

40.

Nathan BP, Bellosta S, Sanan DA, Weisgraber KH, Mahley RW, Pitas RE. Differential effects of apolipoproteins E3 and E4 on neuronal growth in vitro. Science. 1994;264(5160):850–2.CrossRefPubMed

41.

Bellosta S, Nathan BP, Orth M, Dong LM, Mahley RW, Pitas RE. Stable expression and secretion of apolipoproteins E3 and E4 in mouse neuroblastoma cells produces differential effects on neurite outgrowth. J Biol Chem. 1995;270(45):27063–71.CrossRefPubMed

42.

Trommer BL, Shah C, Yun SH, Gamkrelidze G, Pasternak ES, Ye GL, et al. ApoE isoform affects LTP in human targeted replacement mice. Neuroreport. 2004;15(17):2655–8.CrossRefPubMed

43.

Gibson GE, Haroutunian V, Zhang H, Park LC, Shi Q, Lesser M, et al. Mitochondrial damage in Alzheimer’s disease varies with apolipoprotein E genotype. Ann Neurol. 2000;48(3):297–303.CrossRefPubMed

44.

Reiman EM, Chen K, Alexander GE, Caselli RJ, Bandy D, Osborne D, et al. Functional brain abnormalities in young adults at genetic risk for late-onset Alzheimer’s dementia. Proc Natl Acad Sci U S A. 2004;101(1):284–9. doi:10.1073/pnas.2635903100.CrossRefPubMed

45.

Biffi A, Sonni A, Anderson CD, Kissela B, Jagiella JM, Schmidt H, et al. Variants at APOE influence risk of deep and lobar intracerebral hemorrhage. Ann Neurol. 2010;68(6):934–43. doi:10.1002/ana.22134.CrossRefPubMedPubMedCentral

Title: Apolipoprotein E polymorphism and the risk of intracranial aneurysms in a Chinese population
Authors: Hao Liu
Ping Mao
Changhou Xie
Wanfu Xie
Maode Wang
Haitao Jiang
Publication date: 01-12-2016
Publisher: BioMed Central
Published in: BMC Neurology / Issue 1/2016
Electronic ISSN: 1471-2377
DOI: https://doi.org/10.1186/s12883-016-0537-z

At a glance: The STEP trials

Springer Medicine

Apolipoprotein E polymorphism and the risk of intracranial aneurysms in a Chinese population

Abstract

Background

Methods

Results

Conclusion

At a glance: The STEP trials

Springer Medicine

Abstract

Background

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 1/2016

Myasthenic symptoms in anti-low-density lipoprotein receptor-related protein 4 antibody-seropositive amyotrophic lateral sclerosis: two case reports

Time-dependent parameter of perfusion imaging as independent predictor of clinical outcome in symptomatic carotid artery stenosis

Natural Killer (NK) Cell Functionality after human Spinal Cord Injury (SCI): protocol of a prospective, longitudinal study

Clinical trial on tonal tinnitus with tailor-made notched music training

COPPADIS-2015 (COhort of Patients with PArkinson’s DIsease in Spain, 2015), a global –clinical evaluations, serum biomarkers, genetic studies and neuroimaging– prospective, multicenter, non-interventional, long-term study on Parkinson’s disease progression

Cerebrospinal fluid dissemination of anaplastic intraventricular meningioma: report of a case presenting with progressive brainstem dysfunction and multiple cranial nerve palsies